Global gene expression profile progression in Gaucher disease mouse models

BMC Genomics

Volumn 12, Issue , 2011, Pages

  Xu, You Hai ^a   Jia, Li ^a   Quinn, Brian ^a   Zamzow, Matthew ^a   Stringer, Keith ^a   Aronow, Bruce ^a   Sun, Ying ^a   Zhang, Wujuan ^a   Setchell, Kenneth D R ^a   Grabowski, Gregory A ^a  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; MESSENGER RNA; GLYCOSPHINGOLIPID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; GAUCHER DISEASE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE MUTATION; HOMOZYGOSITY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LIPID STORAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PHENOTYPE; POINT MUTATION; UPREGULATION; ANIMAL; DISEASE MODEL; DNA MICROARRAY; GENETICS; METABOLISM; MOUSE MUTANT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

MUS;

ANIMALS; DISEASE MODELS, ANIMAL; GAUCHER DISEASE; GENE EXPRESSION PROFILING; GLYCOSPHINGOLIPIDS; MICE; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 78651067048     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-12-20     Document Type: Article

References (79)

1. Beutler E, Grabowski GA. Gaucher Disease. The Metabolic and Molecular Basis of Inherited Disease 2001, III:3635-3668. New York: McGraw-Hill, Scriver CR, Beaudet AL, Sly WS, Valle D, eighth.
2. Barak V, Acker M, Nisman B, Kalickman I, Abrahamov A, Zimran A, Yatziv S. Cytokines in Gaucher's disease. Eur Cytokine Netw 1999, 10(2):205-210.
3. Hollak CE, Evers L, Aerts JM, van Oers MH. Elevated levels of M-CSF, sCD14 and IL8 in type 1 Gaucher disease. Blood Cells Mol Dis 1997, 23(2):201-212. 10.1006/bcmd.1997.0137, 9236158.
4. Michelakakis H, Spanou C, Kondyli A, Dimitriou E, Van Weely S, Hollak CE, Van Oers MH, Aerts JM. Plasma tumor necrosis factor-a (TNF-a) levels in Gaucher disease. Biochim Biophys Acta 1996, 1317(3):219-222.
5. Boven LA, van Meurs M, Boot RG, Mehta A, Boon L, Aerts JM, Laman JD. Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages. Am J Clin Pathol 2004, 122(3):359-369. 10.1309/BG5VA8JRDQH1M7HN, 15362365.
6. Frings W, Dreier J, Sorg C. Only the soluble form of the scavenger receptor CD163 acts inhibitory on phorbol ester-activated T-lymphocytes, whereas membrane-bound protein has no effect. FEBS Lett 2002, 526(1-3):93-96. 10.1016/S0014-5793(02)03142-3, 12208511.
7. Goerdt S, Politz O, Schledzewski K, Birk R, Gratchev A, Guillot P, Hakiy N, Klemke CD, Dippel E, Kodelja V, et al. Alternative versus classical activation of macrophages. Pathobiology 1999, 67(5-6):222-226. 10.1159/000028096, 10725788.
8. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003, 3(1):23-35. 10.1038/nri978, 12511873.
9. Gratchev A, Guillot P, Hakiy N, Politz O, Orfanos CE, Schledzewski K, Goerdt S. Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein betaIG-H3. Scand J Immunol 2001, 53(4):386-392. 10.1046/j.1365-3083.2001.00885.x, 11285119.
10. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002, 23(11):549-555. 10.1016/S1471-4906(02)02302-5, 12401408.
11. Cuvillier O. Sphingosine in apoptosis signaling. Biochim Biophys Acta 2002, 1585(2-3):153-162.
12. Obeid LM, Linardic CM, Karolak LA, Hannun YA. Programmed cell death induced by ceramide. Science 1993, 259(5102):1769-1771. 10.1126/science.8456305, 8456305.
13. Pettus BJ, Chalfant CE, Hannun YA. Sphingolipids in inflammation: roles and implications. Curr Mol Med 2004, 4(4):405-418. 10.2174/1566524043360573, 15354871.
14. Hong YB, Kim EY, Jung SC. Down-regulation of Bcl-2 in the fetal brain of the Gaucher disease mouse model: a possible role in the neuronal loss. J Hum Genet 2004, 49(7):349-354. 10.1007/s10038-004-0155-2, 15179559.
15. Myerowitz R, Mizukami H, Richardson KL, Finn LS, Tifft CJ, Proia RL. Global gene expression in a type 2 Gaucher disease brain. Mol Genet Metab 2004, 83(4):288-296. 10.1016/j.ymgme.2004.06.020, 15589115.
16. Xu YH, Quinn B, Witte D, Grabowski GA. Viable mouse models of acid beta-glucosidase deficiency: the defect in Gaucher disease. Am J Pathol 2003, 163(5):2093-2101. 1892407, 14578207.
17. Nenan S, Boichot E, Lagente V, Bertrand CP. Macrophage elastase (MMP-12): a pro-inflammatory mediator?. Mem Inst Oswaldo Cruz 2005, 100(Suppl 1):167-172.
18. Shapiro SD, Kobayashi DK, Ley TJ. Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J Biol Chem 1993, 268(32):23824-23829.
19. Lam-Yuk-Tseung S, Gros P. Genetic control of susceptibility to bacterial infections in mouse models. Cell Microbiol 2003, 5(5):299-313. 10.1046/j.1462-5822.2003.00276.x, 12713489.
20. Pradines JR, Farutin V, Rowley S, Dancik V. Analyzing protein lists with large networks: edge-count probabilities in random graphs with given expected degrees. J Comput Biol 2005, 12(2):113-128. 10.1089/cmb.2005.12.113, 15767772.
21. de Fougerolles AR, Chi-Rosso G, Bajardi A, Gotwals P, Green CD, Koteliansky VE. Global expression analysis of extracellular matrix-integrin interactions in monocytes. Immunity 2000, 13(6):749-758. 10.1016/S1074-7613(00)00073-X, 11163191.
22. Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-gamma. Annu Rev Immunol 1997, 15:749-795. 10.1146/annurev.immunol.15.1.749, 9143706.
23. Fenton MJ, Vermeulen MW, Kim S, Burdick M, Strieter RM, Kornfeld H. Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis. Infect Immun 1997, 65(12):5149-5156. 175742, 9393809.
24. Munder M, Eichmann K, Moran JM, Centeno F, Soler G, Modolell M. Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. J Immunol 1999, 163(7):3771-3777.
25. Xing Z, Zganiacz A, Santosuosso M. Role of IL-12 in macrophage activation during intracellular infection: IL-12 and mycobacteria synergistically release TNF-alpha and nitric oxide from macrophages via IFN-gamma induction. J Leukoc Biol 2000, 68(6):897-902.
26. Xaus J, Cardo M, Valledor AF, Soler C, Lloberas J, Celada A. Interferon gamma induces the expression of p21waf-1 and arrests macrophage cell cycle, preventing induction of apoptosis. Immunity 1999, 11(1):103-113. 10.1016/S1074-7613(00)80085-0, 10435583.
27. Gudmundsson G, Hunninghake GW. Interferon-gamma is necessary for the expression of hypersensitivity pneumonitis. J Clin Invest 1997, 99(10):2386-2390. 10.1172/JCI119420, 508077, 9153280.
28. Chiu BC, Freeman CM, Stolberg VR, Komuniecki E, Lincoln PM, Kunkel SL, Chensue SW. Cytokine-chemokine networks in experimental mycobacterial and schistosomal pulmonary granuloma formation. Am J Respir Cell Mol Biol 2003, 29(1):106-116. 10.1165/rcmb.2002-0241OC, 12600821.
29. Jiang Y, Beller DI, Frendl G, Graves DT. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J Immunol 1992, 148(8):2423-2428.
30. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines. Adv Immunol 1994, 55:97-179. full_text, 8304236.
31. Kopydlowski KM, Salkowski CA, Cody MJ, van Rooijen N, Major J, Hamilton TA, Vogel SN. Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo. J Immunol 1999, 163(3):1537-1544.
32. Ohmori Y, Wyner L, Narumi S, Armstrong D, Stoler M, Hamilton TA. Tumor necrosis factor-alpha induces cell type and tissue-specific expression of chemoattractant cytokines in vivo. Am J Pathol 1993, 142(3):861-870. 1886781, 8456945.
33. Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol 1991, 9:617-648.
34. Schall TJ, Bacon KB. Chemokines, leukocyte trafficking, and inflammation. Curr Opin Immunol 1994, 6(6):865-873. 10.1016/0952-7915(94)90006-X, 7710711.
35. Tessier PA, Naccache PH, Clark-Lewis I, Gladue RP, Neote KS, McColl SR. Chemokine networks in vivo: involvement of C-X-C and C-C chemokines in neutrophil extravasation in vivo in response to TNF-alpha. J Immunol 1997, 159(7):3595-3602.
36. VanOtteren GM, Standiford TJ, Kunkel SL, Danforth JM, Strieter RM. Alterations of ambient oxygen tension modulate the expression of tumor necrosis factor and macrophage inflammatory protein-1 alpha from murine alveolar macrophages. Am J Respir Cell Mol Biol 1995, 13(4):399-409.
37. Wu AJ, Kurrasch RH, Katz J, Fox PC, Baum BJ, Atkinson JC. Effect of tumor necrosis factor-alpha and interferon-gamma on the growth of a human salivary gland cell line. J Cell Physiol 1994, 161(2):217-226. 10.1002/jcp.1041610205, 7962105.
38. Dorner BG, Scheffold A, Rolph MS, Huser MB, Kaufmann SH, Radbruch A, Flesch IE, Kroczek RA. MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines. Proc Natl Acad Sci USA 2002, 99(9):6181-6186. 10.1073/pnas.092141999, 122923, 11972057.
39. Gong JH, Ratkay LG, Waterfield JD, Clark-Lewis I. An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model. J Exp Med 1997, 186(1):131-137. 10.1084/jem.186.1.131, 2198969, 9207007.
40. Gunn MD, Nelken NA, Liao X, Williams LT. Monocyte chemoattractant protein-1 is sufficient for the chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus for inflammatory activation. J Immunol 1997, 158(1):376-383.
41. Rand ML, Warren JS, Mansour MK, Newman W, Ringler DJ. Inhibition of T cell recruitment and cutaneous delayed-type hypersensitivity-induced inflammation with antibodies to monocyte chemoattractant protein-1. Am J Pathol 1996, 148(3):855-864. 1861724, 8774140.
42. Zisman DA, Kunkel SL, Strieter RM, Tsai WC, Bucknell K, Wilkowski J, Standiford TJ. MCP-1 protects mice in lethal endotoxemia. J Clin Invest 1997, 99(12):2832-2836. 10.1172/JCI119475, 508132, 9185504.
43. Schindler R, Mancilla J, Endres S, Ghorbani R, Clark SC, Dinarello CA. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 1990, 75(1):40-47.
44. Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 1994, 83(1):113-118.
45. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF, Achong MK. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998, 101(2):311-320. 10.1172/JCI1368, 508569, 9435302.
46. Miller MD, Krangel MS. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit Rev Immunol 1992, 12(1-2):17-46.
47. Emi M, Asaoka H, Matsumoto A, Itakura H, Kurihara Y, Wada Y, Kanamori H, Yazaki Y, Takahashi E, Lepert M, et al. Structure, organization, and chromosomal mapping of the human macrophage scavenger receptor gene. J Biol Chem 1993, 268(3):2120-2125.
48. Wang WW, Jenkinson CP, Griscavage JM, Kern RM, Arabolos NS, Byrns RE, Cederbaum SD, Ignarro LJ. Co-induction of arginase and nitric oxide synthase in murine macrophages activated by lipopolysaccharide. Biochem Biophys Res Commun 1995, 210(3):1009-1016. 10.1006/bbrc.1995.1757, 7539253.
49. de Vera ME, Shapiro RA, Nussler AK, Mudgett JS, Simmons RL, Morris SM, Billiar TR, Geller DA. Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter. Proc Natl Acad Sci USA 1996, 93(3):1054-1059. 10.1073/pnas.93.3.1054, 40029, 8577713.
50. Mock BA, Krall MM, Byrd LG, Chin H, Barton CH, Charles I, Liew FY, Blackwell J. The inducible form of nitric oxide synthase (NOS2) isolated from murine macrophages maps near the nude mutation on mouse chromosome 11. Eur J Immunogenet 1994, 21(4):231-238. 10.1111/j.1744-313X.1994.tb00196.x, 9098436.
51. Rossi A, Kapahi P, Natoli G, Takahashi T, Chen Y, Karin M, Santoro MG. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature 2000, 403(6765):103-108. 10.1038/47520, 10638762.
52. Leibovich SJ, Polverini PJ, Fong TW, Harlow LA, Koch AE. Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. Proc Natl Acad Sci USA 1994, 91(10):4190-4194. 10.1073/pnas.91.10.4190, 43750, 7514298.
53. Xiong M, Elson G, Legarda D, Leibovich SJ. Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway. Am J Pathol 1998, 153(2):587-598. 1852978, 9708818.
54. Corraliza IM, Soler G, Eichmann K, Modolell M. Arginase induction by suppressors of nitric oxide synthesis (IL-4, IL-10 and PGE2) in murine bone-marrow-derived macrophages. Biochem Biophys Res Commun 1995, 206(2):667-673. 10.1006/bbrc.1995.1094, 7530004.
55. Hogger P, Dreier J, Droste A, Buck F, Sorg C. Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid-inducible member of the scavenger receptor cysteine-rich family (CD163). J Immunol 1998, 161(4):1883-1890.
56. Stein M, Keshav S, Harris N, Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 1992, 176(1):287-292. 10.1084/jem.176.1.287, 2119288, 1613462.
57. Bonecchi R, Sozzani S, Stine JT, Luini W, D'Amico G, Allavena P, Chantry D, Mantovani A. Divergent effects of interleukin-4 and interferon-gamma on macrophage-derived chemokine production: an amplification circuit of polarized T helper 2 responses. Blood 1998, 92(8):2668-2671.
58. Imai T, Nagira M, Takagi S, Kakizaki M, Nishimura M, Wang J, Gray PW, Matsushima K, Yoshie O. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 1999, 11(1):81-88. 10.1093/intimm/11.1.81, 10050676.
59. Lang R, Kocourek A, Braun M, Tschesche H, Huber R, Bode W, Maskos K. Substrate specificity determinants of human macrophage elastase (MMP-12) based on the 1.1 A crystal structure. J Mol Biol 2001, 312(4):731-742. 10.1006/jmbi.2001.4954, 11575928.
60. Liu WH, Chen XM, Fu B. Thrombin stimulates MMP-9 mRNA expression through AP-1 pathway in human mesangial cells. Acta Pharmacol Sin 2000, 21(7):641-645.
61. Belaaouaj A, Shipley JM, Kobayashi DK, Zimonjic DB, Popescu N, Silverman GA, Shapiro SD. Human macrophage metalloelastase. Genomic organization, chromosomal location, gene linkage, and tissue-specific expression. J Biol Chem 1995, 270(24):14568-14575. 10.1074/jbc.270.24.14568, 7782320.
62. Xie S, Issa R, Sukkar MB, Oltmanns U, Bhavsar PK, Papi A, Caramori G, Adcock I, Chung KF. Induction and regulation of matrix metalloproteinase-12 in human airway smooth muscle cells. Respir Res 2005, 6:148. 10.1186/1465-9921-6-148, 1363355, 16359550.
63. Qu P, Du H, Wang X, Yan C. Matrix metalloproteinase 12 overexpression in lung epithelial cells plays a key role in emphysema to lung bronchioalveolar adenocarcinoma transition. Cancer Res 2009, 69(18):7252-7261. 10.1158/0008-5472.CAN-09-0577, 2753283, 19706765.
64. Shukla A, Barrett TF, Nakayama KI, Nakayama K, Mossman BT, Lounsbury KM. Transcriptional up-regulation of MMP12 and MMP13 by asbestos occurs via a PKCdelta-dependent pathway in murine lung. Faseb J 2006, 20(7):997-999. 10.1096/fj.05-4554fje, 16571779.
65. Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, Moestrup SK. Identification of the haemoglobin scavenger receptor. Nature 2001, 409(6817):198-201. 10.1038/35051594, 11196644.
66. Gabay C, Porter B, Guenette D, Billir B, Arend WP. Interleukin-4 (IL-4) and IL-13 enhance the effect of IL-1beta on production of IL-1 receptor antagonist by human primary hepatocytes and hepatoma HepG2 cells: differential effect on C-reactive protein production. Blood 1999, 93(4):1299-1307.
67. Mantovani A, Locati M, Vecchi A, Sozzani S, Allavena P. Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. Trends Immunol 2001, 22(6):328-336. 10.1016/S1471-4906(01)01941-X, 11377293.
68. Peiser L, Mukhopadhyay S, Gordon S. Scavenger receptors in innate immunity. Curr Opin Immunol 2002, 14(1):123-128. 10.1016/S0952-7915(01)00307-7, 11790542.
69. Fernandes C, Paya-Cano JL, Sluyter F, D'Souza U, Plomin R, Schalkwyk LC. Hippocampal gene expression profiling across eight mouse inbred strains: towards understanding the molecular basis for behaviour. Eur J Neurosci 2004, 19(9):2576-2582. 10.1111/j.0953-816X.2004.03358.x, 15128411.
70. Korostynski M, Kaminska-Chowaniec D, Piechota M, Przewlocki R. Gene expression profiling in the striatum of inbred mouse strains with distinct opioid-related phenotypes. BMC Genomics 2006, 7:146. 10.1186/1471-2164-7-146, 1553451, 16772024.
71. Pavlidis P, Noble WS. Analysis of strain and regional variation in gene expression in mouse brain. Genome Biol 2001, 2(10):RESEARCH0042. 10.1186/gb-2001-2-10-research0042, 57797, 11597334.
72. Sandberg R, Yasuda R, Pankratz DG, Carter TA, Del Rio JA, Wodicka L, Mayford M, Lockhart DJ, Barlow C. Regional and strain-specific gene expression mapping in the adult mouse brain. Proc Natl Acad Sci USA 2000, 97(20):11038-11043. 10.1073/pnas.97.20.11038, 27144, 11005875.
73. Bianchi-Frias D, Pritchard C, Mecham BH, Coleman IM, Nelson PS. Genetic background influences murine prostate gene expression: implications for cancer phenotypes. Genome Biol 2007, 8(6):R117. 10.1186/gb-2007-8-6-r117, 2394769, 17577413.
74. Burne MJ, Haq M, Matsuse H, Mohapatra S, Rabb H. Genetic susceptibility to renal ischemia reperfusion injury revealed in a murine model. Transplantation 2000, 69(5):1023-1025. 10.1097/00007890-200003150-00065, 10755573.
75. Rosas LE, Keiser T, Barbi J, Satoskar AA, Septer A, Kaczmarek J, Lezama-Davila CM, Satoskar AR. Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice. Int Immunol 2005, 17(10):1347-1357. 10.1093/intimm/dxh313, 16141242.
76. Scott MJ, Hoth JJ, Gardner SA, Peyton JC, Cheadle WG. Genetic background influences natural killer cell activation during bacterial peritonitis in mice, and is interleukin 12 and interleukin 18 independent. Cytokine 2004, 28(3):124-136. 10.1016/j.cyto.2004.07.006, 15473954.
77. Sun Y, Quinn B, Witte DP, Grabowski GA. Gaucher disease mouse models: point mutations at the acid beta-glucosidase locus combined with low-level prosaposin expression lead to disease variants. J Lipid Res 2005, 46(10):2102-2113. 10.1194/jlr.M500202-JLR200, 16061944.
78. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 2003, 31(4):e15. 10.1093/nar/gng015, 150247, 12582260.
79. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001, 125(1-2):279-284. 10.1016/S0166-4328(01)00297-2, 11682119.